Patents
Patents for A61K 51 - Preparations containing radioactive substances for use in therapy or testing in vivo (24,291)
11/1991
11/08/1991CA2082265A1 Method for radiolabeling monovalent antibody fragments
11/07/1991DE4014762A1 Cpds. for radiation therapy or diagnostics contg. Mossbauer nuclides - esp. ruthenium or iron in isotopically enriched form in metallocene or half-sandwich-carbonyl complexes
11/06/1991EP0455268A1 Biologically useful conjugates
11/05/1991CA1291710C Tetrapyrrole therapeutic agents
10/1991
10/31/1991WO1991016355A1 Method for increasing blood-brain barrier permeability
10/31/1991WO1991016075A1 Bone marrow treatments
10/31/1991CA2081308A1 Method for increasing blood-brain barrier permeability
10/30/1991EP0454185A2 Utilisation of fluoron derivatives as contrast agents for malignant tissues when diagnosed
10/30/1991EP0454078A2 Dual functioning excipient for metal chelate contrast agents
10/30/1991EP0453560A1 Localization and characterization of the wilms's tumor gene
10/30/1991EP0453507A1 Chelating agent derivatives
10/30/1991EP0453482A1 Biologically active synthetic thyrotropin and cloned gene for producing same
10/29/1991US5061724 Applying mixture of absorbable skin cream and indomethcin placed in a bandage to skin area
10/29/1991US5061641 Method for radiolabeling proteins
10/29/1991US5061476 Radiolabeled colloid compositions and method for preparing same
10/29/1991US5061475 Injection into affected joint
10/23/1991EP0453082A1 Trifunctional antibody-like compounds as a combined diagnostic and therapeutic agent
10/23/1991EP0452858A2 Metal complexes of acid adducts to dioxime ligands useful in labelling proteins and other amine-containing compounds
10/22/1991US5059541 Minimal derivatization of proteins
10/22/1991US5059413 Scintigraphic monitoring of immunotoxins using radionuclides and heterobifunctional chelators
10/22/1991US5059412 Macrocyclic aminophosphonic acid complexes for the treatment of calcific tumors
10/22/1991US5059166 Intra-arterial stent with the capability to inhibit intimal hyperplasia
10/18/1991WO1991016076A1 Method and kit for preparing technetium-99m complexes
10/18/1991CA2080685A1 Method and kit for preparing technetium-99m complexes
10/17/1991WO1991015467A1 Aminopolycarboxylic acid chelating agents
10/17/1991WO1991015466A2 Aminopolycarboxylic acid chelating agents
10/17/1991WO1991015240A1 Method of preparing an iron oxide composition for therapeutic treatment of a living body and iron oxide composition
10/16/1991EP0451880A2 An ex vivo tissue perfusion composition and the use thereof
10/16/1991EP0451824A2 Chelating compounds and their use
10/16/1991EP0210269B1 X-ray-emitting interstitial implants
10/16/1991EP0193561B1 Monoclonal antibodies against metal chelates
10/15/1991US5057313 Diagnostic and therapeutic antibody conjugates
10/15/1991US5057301 Fluorinated sugars
10/08/1991US5055404 Monoclonal antibody specifically reactive to surface of human prostatic epithelial cells
10/03/1991WO1991014460A1 Contrast media
10/03/1991WO1991014453A1 Improved method to directly radiolabel antibodies for diagnostic imaging and therapy
10/03/1991CA2079212A1 Contrast media
10/01/1991US5053503 For joining antibodies and metallic radionuclides
10/01/1991US5053493 Method for labeling antibodies with a metal ion
10/01/1991US5053491 Stimulate hormonal secretion; highly specific imaging technique, radioactive labeling
10/01/1991US5053186 Soluble irradiation targets and methods for the production of radiorhenium
09/1991
09/30/1991WO1991014685A1 Complexes of thioethers
09/30/1991CA2079221A1 Complexes of thioethers
09/27/1991WO1991014459A1 A bifunctional dtpa-type ligand
09/27/1991WO1991014458A1 A fonctionalized complexand
09/27/1991CA2079206A1 Fonctionalized complexand
09/25/1991EP0448191A1 1,4,7,10-Tetraazacyclododecane-butyltriols, process for their preparation, and pharmaceutical agents containing these compounds
09/25/1991EP0447489A1 Human platelet-specific antibodies
09/24/1991WO1991014664A1 Metal complexes
09/24/1991CA2058288A1 Metal complexes
09/24/1991CA1289474C Antibodies useable as pilot agents, and compounds containing same
09/20/1991CA2332618A1 Liquid lavage/ventilation of the pulmonary system
09/19/1991WO1991013633A1 Improvements relating to immunoradiotherapy
09/19/1991WO1991013631A1 Method for enhancing antibody transport through capillary barriers
09/18/1991EP0446213A1 Vertical reaction vessel
09/17/1991US5049667 Nitrogen-containing cyclic ligands
09/17/1991US5049374 Nuclear medicine
09/17/1991US5049373 Immunology
09/17/1991US5049284 Method of removing radioactive europium from solutions of radioactive gadolinium
09/11/1991EP0446143A2 Polysaccharidic delipidated compounds, process for their preparation and compositions containing them
09/11/1991EP0445976A1 Gamma emitting, CCK-A antagonists for pancreatic imaging
09/11/1991EP0445236A1 Tumor imaging with technetium labeled carbohydrates.
09/11/1991EP0445235A1 Method of imaging coronary thrombi
09/11/1991EP0445190A1 Pharmaceutical product having, in particular, a cardiac tropism comprising a nitruro complex of a transition metal and process for preparation thereof.
09/10/1991US5047227 Novel and improved antibodies for site specific attachment of compounds
09/10/1991US5046499 Method for myocardial infarct risk assessment
09/10/1991CA2037835A1 Tri-functional antibody-like compounds as a combined diagnostic and therapeutics agent
09/10/1991CA1288693C Mossbauer cancer therapy
09/10/1991CA1288688C Method for the diagnosis and treatment of inflammation
09/09/1991CA2037741A1 Delipidated polysaccharide composition, method for preparing same
09/05/1991WO1991013095A1 Hypoxia-induced proteins including an activator of coagulation factor x and methods of preparation and use
09/04/1991EP0444194A1 Agent for thermotherapy
09/04/1991EP0444130A1 TECHNETIUM-99m COMPLEX FOR EXAMINING THE RENAL FUNCTION
09/03/1991WO1991013166A1 Antibody constructs with enhanced binding affinity
09/03/1991US5045302 Ligands and cationic complexes thereof with technetium-99m
09/03/1991CA2077348A1 Antibody constructs with enhanced binding affinity
08/1991
08/29/1991DE4104308A1 Therapeutische verwendung von somatostatinpeptiden Therapeutic use of somatostatinpeptiden
08/28/1991EP0443479A1 Process for producing Actinium-225 and Bismuth-213
08/28/1991CN1054070A Boronic acid adducts of rhenium dioxime and technetium-99m dioxime complexes containing biochemically active group
08/27/1991CA1288197C Metal ion labeling of carrier molecules
08/24/1991WO1991013443A1 Process for producing actinium-225 and bismuth-213
08/21/1991EP0441953A1 New cores for technetium radiopharmaceuticals.
08/21/1991EP0441821A1 Probe for detection of the fragile x syndrome
08/15/1991WO1991012332A1 Monoclonal antibodies for recognizing a peptide linked to a major histocompatibility antigen
08/15/1991CA2051651A1 Monoclonal antibodies recognizing a peptide associated with a major histocompatibility antigen
08/14/1991EP0441491A1 Boronic acid adducts of rhenium dioxime and technetium-99M dioxime complexes containing a biochemically active group
08/14/1991EP0440647A1 Labeled nucleic acid probe
08/14/1991EP0440606A1 Macrocyclic chelating agents and chelates thereof
08/13/1991US5039511 Amyloidosis and alzheimer's disease diagnostic assay and reagents therefor
08/13/1991US5039326 Composition and method for radiation synovectomy of arthritic joints
08/13/1991CA1287576C Procedure for isolating and purifying radioactive ligated rhenium pharmaceuticals and use thereof and kit
08/07/1991EP0439871A2 Myocardial-path technetium complex compounds and process for their production
08/07/1991EP0439797A1 Antibodies specifically recognizing somatotropin binding protein
08/06/1991US5038046 Method and generator for producing radioactive lead-212
08/06/1991US5037631 Technetium-99M complex for examinating the renal function
08/06/1991US5037630 Metal radionuclide labeled proteins for diagnosis and therapy
08/01/1991CA2035200A1 Antibodies specifically recognizing somatotropin binding protein
07/1991
07/31/1991EP0438527A1 Radiolabelled particulate composition
07/31/1991EP0438502A1 Technetium imaging agents.
07/30/1991US5035995 Test method involving substance-conjugated complement component C1q